Back to Search Results

Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.

Service d'Endocrinologie-Métabolisme, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France. eric.bruckert@psl.ap-hop-paris.fr

Circulation. 2003;(25):3124-8
Full text from:

Other resources

Methodological quality

Publication Type : Case Reports ; Review

Metadata